Edition:
United States

People: Align Technology Inc (ALGN.O)

ALGN.O on Nasdaq

91.70USD
20 Jan 2017
Change (% chg)

$1.15 (+1.27%)
Prev Close
$90.55
Open
$90.89
Day's High
$92.03
Day's Low
$90.86
Volume
822,176
Avg. Vol
903,149
52-wk High
$102.10
52-wk Low
$57.31

Morrow, George 

Mr. George J. Morrow is an Independent Director of Align Technology Inc., From February 2011 until January 2013, Mr. Morrow served as a consultant to Amgen Inc., a global biotechnology company. From 2003 until his retirement in February 2011, he was the Executive Vice President, Global Commercial Operations at Amgen Inc., where he also served as Executive Vice President of Worldwide Sales and Marketing between 2001 and 2003. From 1992 to 2001, Mr. Morrow held multiple leadership positions at GlaxoSmithKline Inc. and its subsidiaries, including President and Chief Executive Officer of Glaxo Wellcome Inc. He is a member of the board of directors of Vical Incorporated, a company that researches and develops biopharmaceutical products, Safeway Inc., a food and drug retailer and was a member of the board of directors of Human Genome Sciences, Inc., a biopharmaceutical discovery and development company, from March 2011 until its acquisition in August 2012 by GlaxoSmithKline plc. Mr. Morrow holds a B.S. in Chemistry from Southampton College, Long Island University, an M.S. in Biochemistry from Bryn Mawr College and an M.B.A. from Duke University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Charles Larkin

--

Joseph Hogan

17,383,000

John Morici

--

Emory Wright

3,111,530

Roger George

1,852,250

Simon Beard

--
As Of  30 Dec 2015